Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03652012 · ClinicalTrials.gov registry record · NA

Probing Cortical Excitability and Cognitive Function With TMS

A NA study, sponsored by University of Arizona.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT03652012: Completed NA study, sponsored by University of Arizona.

NCT03652012 is a NA study that has completed, run by University of Arizona. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03652012, a NA study, has completed, sponsored by University of Arizona.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

The overarching purpose of this study is to develop a technique that is capable of identifying neurophysiological biomarkers sensitive enough to detect preclinical dementia by integrating Transcranial Magnetic Stimulation (TMS) and Functional Magnetic Resonance Imaging (fMRI). More specifically, this project has two specific aims: * 1\. To characterize cortical excitability and its relation to cognitive function using single-pulse TMS paradigm in Mild Cognitive Impairment (MCI) and healthy older adults. * 2\. To delineate cortical plasticity and its association to cognitive function using repetitive TMS paradigm and resting-state fMRI in MCI and healthy older adults. Techniques to artificially and precisely stimulate brain tissue are increasingly recognized as valuable tools both in clinical practice and in cognitive neuroscience studies among healthy individuals. Transcranial magnetic stimulation (TMS) is a non-invasive approach to stimulate the brain. Importantly, unlike other invasive brain stimulation techniques (e.g., surgical deep brain stimulation), no surgery, anesthesia, or sedation is involved. Instead, TMS involves placing a magnetic coil on the surface of the head. This coil then generates a magnetic field that is about the same strength as the magnetic field used by MRI machines, and when this magnetic field rapidly alternates, the neurons under the coil are excited. Extensive guidelines have been published by experts in the field to ensure safe use, and the thousands of patients \& research participants who have received TMS in compliance with these guidelines demonstrate the safety of this practice. Depending on the method of use, TMS is very versatile -- it can be used to study research questions pertaining to the neural circuitry of the brain, it can be used as a diagnostic device, and it can be used therapeutically to treat various neurological conditions. In this study, the investigators intend to further study the potential for diagnostic app

Primary Outcome

Resting motor threshold (rMT) was determined using the Parameter Estimation by Sequential Testing (PEST) algorithm during a single-pulse transcranial magnetic stimulation (TMS) protocol. Surface electromyography (EMG) was used to record motor evoked potentials (MEPs) from the target muscle. rMT was defined as the minimum stimulation intensity over the motor cortex hotspot required to elicit an MEP of at least 50 μV in peak-to-peak amplitude in 50% of trials. Stimulation intensity on the TMS dev

Interventions

  • DEVICE Transcranial Magnetic Stimulation (TMS)

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2018-04-03
Est. Completion 2020-03-04
Phase NA
University of Arizona

349 total trials

What the finished NCT03652012 record still lists

NCT03652012 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Transcranial Magnetic Stimulation (TMS) is the first listed.

NCT03652012 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03652012 about?

NCT03652012 is a clinical study titled "Probing Cortical Excitability and Cognitive Function With TMS". The overarching purpose of this study is to develop a technique that is capable of identifying neurophysiological biomarkers sensitive enough to detect preclinical dementia by integrating Transcranial Magnetic Stimulation (TMS) and Functional Magnetic Resonance Imaging (fMRI). More specifically, thi...

What is the current status of trial NCT03652012?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2018-04-03. Estimated completion is 2020-03-04.

What interventions are being tested in trial NCT03652012?

The interventions under investigation include: Transcranial Magnetic Stimulation (TMS) (DEVICE).

Who is sponsoring clinical trial NCT03652012?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03652012's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03652012, the US trial registry maintained by the National Library of Medicine. NCT03652012 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.